Ryoichi Miura - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Ryoichi Miura's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Ryoichi Miura
Verified
Publisher and CEO, NY Seikatsu
New York
Beats
Primarily media analysis, accessibility but I'm always expanding to new topics and I'm open to almost anything, disability podcasting, and culture
Content
Time trend of outcomes according to systemic therapy for patients with unresectable hepatocellular carcinoma: A single‐institution study
By Shinsuke Uchikawa, Tomokazu Kawaoka, Serami Murakami, Ryoichi Miura Verified| Wiley Online Library Verified AFP α-fetoprotein BCLC Barcelona Clinic Liver Cancer EHM extrahepatic metastasis HCC hepatocellular carcinoma MTA molecular targeted agent MVI macroscopic vascular invasion OS overall survival TNM tumor node metastasis INTRODUCTION Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide.1 HCC commonly occurs in patients with chronic hepatitis or liver cirrhosis due to viral infection, alcohol use, or metabolic dysfunction-associated steatohepatits.2...
Time trend of outcomes according to systemic therapy for patients with unresectable hepatocellular carcinoma: A single‐institution study
By Shinsuke Uchikawa, Tomokazu Kawaoka, Serami Murakami, Ryoichi Miura Verified| Wiley Online Library Verified AFP α-fetoprotein BCLC Barcelona Clinic Liver Cancer EHM extrahepatic metastasis HCC hepatocellular carcinoma MTA molecular targeted agent MVI macroscopic vascular invasion OS overall survival TNM tumor node metastasis INTRODUCTION Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide.1 HCC commonly occurs in patients with chronic hepatitis or liver cirrhosis due to viral infection, alcohol use, or metabolic dysfunction-associated steatohepatits.2...
Company Info
NY Seikatsu
New York, New York, United States
+1 212-213-6069